Comparative Pharmacology

Head-to-head clinical analysis: DIALYTE LM DEXTROSE 2 5 IN PLASTIC CONTAINER versus DIANEAL PD 1 W DEXTROSE 1 5 IN PLASTIC CONTAINER.

Peer-Reviewed Evidence

Differential Analysis

DIALYTE LM/ DEXTROSE 2.5% IN PLASTIC CONTAINER vs DIANEAL PD-1 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER

Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.

DIALYTE LM/ DEXTROSE 2.5% IN PLASTIC CONTAINER

Peritoneal Dialysis Solution

Category C

DIANEAL PD-1 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER

Peritoneal Dialysis Solution

Category C

Head-to-Head

Clinical Matrix

Mechanism of Action

Dialysis solution containing dextrose and electrolytes; dextrose provides osmotic gradient for ultrafiltration and caloric supplementation, while electrolytes maintain acid-base and electrolyte balance in peritoneal dialysis.

Dianeal PD-1 with Dextrose 1.5% is a peritoneal dialysis solution that uses dextrose as an osmotic agent to create a concentration gradient across the peritoneal membrane, facilitating the removal of waste products (e.g., urea, creatinine) and excess fluid from the blood into the peritoneal cavity via diffusion and ultrafiltration.

Clinical Dosing

Intravenous infusion, 500-2000 mL per day as maintenance fluid; rate adjusted based on clinical status, typically 1-2 mL/kg/hour in adults.

2 L intraperitoneally via continuous ambulatory peritoneal dialysis (CAPD) four times daily, with dwell times of 4-6 hours each. For automated peritoneal dialysis (APD), 2 L per cycle with 4-5 cycles overnight.

Direct Interaction

None Documented